Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects significant challenges, including market pressures, financial constraints, and execution risks. The Q&A section reveals uncertainty in management's plans, particularly regarding technology platform balancing and DoE loan approval. While there are efforts to reduce cash burn and increase liquidity, the negative financial results and lack of clear guidance suggest a cautious outlook. The absence of shareholder return discussions further weakens sentiment, leading to a negative prediction for stock price movement.
Net Loss (Q4 2023) $24 million net loss, compared to a net income of $25 million in Q4 2022. The previous year's income included a $60 million non-cash gain on warrant liability fair value adjustment.
Net Loss (Full Year 2023) $72 million net loss, compared to a loss of $99 million in 2022. The previous year's loss included warrant liability fair value adjustments of $32 million compared to $14 million in 2023.
Cash Position (End of 2023) $276 million in cash at the end of 2023, following a restructuring that incurred a $6 million one-time severance charge.
Total Assets (End of 2023) $732 million in total assets, including net PP&E of $366 million.
Total Liabilities (End of 2023) $97 million in total liabilities, with no debt.
Total Shareholders’ Equity (End of 2023) $635 million, implying a book value of $4.54 per share.
Total Cash Spending (2023) $287 million, which was under budget due to a reduction in the scope of Giga Arctic spending.
Cash Burn Rate (2024) Significant reduction in annual cash burn rate as part of a cost-cutting and resource prioritization program.
Employee Headcount Reduction (2024) Expected reduction of 22% in employee headcount and 26% in consultants and project support personnel by the end of Q1 2024.
Production of Electrodes: FREYR has proven its capability to produce electrochemically active electrodes through fully automated production of anodes and cathodes using next-generation 24M technology.
Automated Battery Production: FREYR is on track to start fully automated production of batteries for customer testing in the first half of 2024.
Semi-Solid Technology: The company is focused on demonstrating the semi-solid technology at Giga scale at the CQP in H1 2024.
EV Sales Growth: EV sales showed 69% growth year-over-year from January 2023 to January 2024, surpassing 1 million cars for the first time.
ESS Market Growth: The ESS market in 2023 was twice as high as initial estimates, closing above 100 gigawatt hours per year.
Cash Outflow Reduction: FREYR has cut cash outflow by more than half year-on-year.
Organizational Restructuring: The company has flattened its organizational structure to enhance collaboration and execution.
Cost Cutting Initiatives: FREYR has initiated a significant cost-cutting program focusing on the CQP and Giga America.
Re-domiciliation: FREYR successfully re-domiciled from Luxembourg to the U.S. as of December 31, 2023, expanding opportunities for equity index inclusion.
Capital Formation Initiatives: The company is focused on securing conditional commitment from the DoE before the end of 2024.
Market Challenges: FREYR is navigating strong headwinds in the market, including competitive pressures from established players, particularly in China, where current installed capacity exceeds demand but faces export challenges.
Regulatory Issues: The company is focused on securing a conditional commitment from the Department of Energy (DoE) for its Title 17 application, which is critical for capital formation.
Supply Chain Challenges: The battery production process is capital intensive, and the company is working closely with a global network of vendors and strategic partners to mitigate risks associated with supply chain disruptions.
Economic Factors: Interest rates are high, impacting capital flows and investment decisions, which could affect the company's ability to secure funding for projects.
Operational Risks: The transition from installation to production at the CQP is a significant milestone, and any delays could impact customer testing and subsequent sales.
Financial Risks: FREYR reported a net loss of $72 million for the full year 2023, indicating ongoing financial challenges that could affect future operations and growth.
Cost Management: The company has initiated a significant cost-cutting program to reduce cash burn and extend liquidity, which may impact operational capabilities in the short term.
Production Milestones: FREYR is on track to start fully automated production of batteries for testing by customers in the first half of 2024.
Technology Strategy: FREYR is developing next-generation battery solutions that will be cost-advantaged relative to conventional solutions.
Capital Formation Initiatives: FREYR is focused on two capital formation initiatives: the DoE Title 17 application and project-level equity discussions for Giga America.
Partnerships: FREYR is cultivating partnerships across the cell production technology spectrum to accelerate commercialization.
CQP Progress: The CQP is transitioning from installation to production of sample battery cells for key customers, which is a priority for the first half of 2024.
Cash Position: FREYR exited 2023 with cash of $276 million, ensuring a two-year cash runway into 2026.
Cost Reduction: FREYR has initiated a significant cost-cutting program, focusing on the CQP and Giga America, while pausing Giga Arctic.
Revenue Expectations: FREYR is targeting customer validation of the semi-solid process and product performance characteristics to trigger offtake conversions.
DoE Title 17 Commitment: FREYR aims to secure a conditional commitment from the DoE before the end of 2024.
Production Start: FREYR anticipates startup production at Giga America in 2026.
Shareholder Return Plan: FREYR Battery has not announced any specific share buyback or dividend program during the call. The focus remains on capital formation initiatives and operational advancements.
The earnings call reflects significant challenges, including market pressures, financial constraints, and execution risks. The Q&A section reveals uncertainty in management's plans, particularly regarding technology platform balancing and DoE loan approval. While there are efforts to reduce cash burn and increase liquidity, the negative financial results and lack of clear guidance suggest a cautious outlook. The absence of shareholder return discussions further weakens sentiment, leading to a negative prediction for stock price movement.
The earnings call reveals mixed signals: significant reduction in net loss and extended cash runway are positive, but increased expenses and unclear timelines for key projects pose concerns. The Q&A section highlights management's optimism about technology and market potential, yet lacks specificity in addressing delays and partnerships. The absence of a new partnership announcement or strong guidance further tempers expectations. Overall, these factors suggest a neutral stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.